Comments
Loading...
Immutep (NASDAQ:IMMP) Stock Quotes, Forecast and News Summary
Immutep Stock (NASDAQ: IMMP) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Immutep (IMMP) stock?
You can purchase shares of Immutep (NASDAQ:IMMP) through any online brokerage.
Who are Immutep (IMMP) competitors?
Other companies in Immutep’s space includes: Precigen (NASDAQ:PGEN), Voyager Therapeutics (NASDAQ:VYGR), Sage Therapeutics (NASDAQ:SAGE), Fate Therapeutics (NASDAQ:FATE) and Tevogen Bio Holdings (NASDAQ:TVGN).
What is the forecast, or price target, for Immutep (IMMP) stock?
Immutep has a consensus price target of $9.00.
What is the current price for Immutep (IMMP)?
The stock price for Immutep (NASDAQ: IMMP) is $2.04 last updated November 25, 2024 at 11:21 AM EST.
Does Immutep (IMMP) pay a dividend?
There are no upcoming dividends for Immutep.
When is Immutep (NASDAQ:IMMP) reporting earnings?
Immutep’s FY earnings are confirmed for Friday, December 6, 2024.
Is Immutep (IMMP) going to split?
There is no upcoming split for Immutep.
What sector and industry does Immutep (IMMP) operate in?
Immutep is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.